2023 Form 5500 filing — Gsk 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240709125037NAL0007873219001) for Gsk 401(K) Plan, reported by Glaxosmithkline LLC under EIN 23-1099050 and plan number 002. It reports 22,031 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20240709125037NAL0007873219001
Filing year
2023
Form type
2
Plan sponsor
Glaxosmithkline LLC
EIN
23-1099050
Plan number
002
Location
Philadelphia, PA
Participants
22,031
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$8,072,931,460
Total liabilities (EOY)
$1,298,881
Net assets (EOY)
$8,071,632,579
Employer contributions
$238,896,307
Participant contributions
$196,465,861
Total income / additions
$1,711,335,304
Benefits paid
$603,233,395
Administrative expenses
$7,370,708
Total expenses
$610,694,155
Net increase / (decrease)
$1,100,641,149
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Alight Financial Advisors LLCNONE$3,382,280not reported in the loaded dataset
Dodge & CoxNONE$2,007,964$0
BlackrockNONE$1,052,743$0
State Street Global AdvisorsTRUSTEE$520,858$0
Gsam Stable Value, LLCNONE$406,863not reported in the loaded dataset

Related Form 5500 pages